Castle Biosciences Inc (CSTL)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -311.752 | -63.075 | 4.208 | -3.679 | -6.939 | -14.757 | -12.761 |
Return on Equity (%) | 60.85 | 19.018 | 20.954 | -4.107 | -7.564 | -16.559 | -14.541 |
Return on Invested Capital (%) | -1274.843 | -56.879 | 12.612 | -2.566 | -7 | -15.644 | -15.094 |
Operating Margin (%) | -77.868 | -17.923 | 19.127 | -12.077 | -42.526 | -50.268 | -26.095 |
Net Profit Margin (%) | -111.291 | -44.602 | 5.767 | -16.415 | -33.259 | -48.992 | -26.146 |
Book Value Per Share | -6.19 | -4.312 | 4.968 | 16.754 | 12.72 | 10.75 | 10.179 |
Earnings Per Share | -6.621 | -4.351 | 0.175 | -0.414 | -1.233 | -2.646 | -2.135 |
Cash Per Share | 0.524 | 1.917 | 5.77 | 16.518 | 12.988 | 4.845 | 3.673 |
Working Capital Per Share | 0.633 | 4.875 | 5.919 | 16.473 | 12.958 | 10.094 | 9.214 |
Operating Profit Per Share | 3.92 | 7.572 | 2.617 | 2.224 | 3.141 | 4.949 | 6.561 |
EBIT Per Share | -5.346 | -2.722 | 0.312 | -0.411 | -1.577 | -2.715 | -2.132 |
EBITDA Per Share | -5.346 | -2.722 | 0.312 | -0.411 | -1.577 | -2.715 | -2.132 |
Free Cash Flow Per Share | -6.541 | -4.37 | 0.208 | -0.242 | 1.26 | -2.839 | -2.087 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | 1.28 | 2.691 | 7.632 | 20.578 | 14.215 | 8.09 | 6.202 |
Quick Ratio | 1.123 | 2.459 | 7.423 | 20.244 | 13.94 | 7.808 | 5.903 |
Inventory Turnover (Days) | 8.094 | 14.128 | 8.705 | 12.916 | 7.84 | 10.601 | 13.189 |
Shares Outstanding | 2.31M | 2.34M | 17.13M | 24.81M | 25.38M | 25.38M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | N/A | 26.35M | 25.38M | N/A | 26.55M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -69.429 | N/A | N/A | N/A | -3.392 |
Net Profit Margin (%) | N/A | N/A | N/A | -69.472 | N/A | N/A | N/A | -3.472 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 8.994 | N/A | N/A | N/A | 9.255 |
Quick Ratio | N/A | N/A | N/A | 8.618 | N/A | N/A | N/A | 8.821 |
Inventory Turnover (Days) | N/A | N/A | N/A | 39.246 | N/A | N/A | N/A | 38.239 |
Market Cap | 549.38M |
Price to Earnings Ratio | -9.74 |
Price to Sales Ratio | 2.55 |
Price to Cash Ratio | 5.66 |
Price to Book Ratio | 1.43 |
Dividend Yield | - |
Shares Outstanding | 27.61M |
Average Volume (1 week) | 384.09k |
Average Volume (1 Month) | 397.96k |
52 Week Change | 21.50% |
52 Week High | 25.91 |
52 Week Low | 12.07 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.